Pooled Analysis of Single-arm Studies of Budesonide/Glycopyrronium/Formoterol (BGF) in Routine Care Setting
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18+
SponsorAstraZeneca
About this trial
The CHOROS pooled analysis is a retrospective secondary data use analysis of integrated individual participant data from a series of planned and on-going primary prospective, non-interventional, multi-center studies sponsored by AstraZeneca and conducted in the pulmonary/primary care practitioner setting in multiple countries and may include data from the following countries: United Kingdom, Germany, Italy, Greece, Japan, Canada and Romania.
Eligibility criteria
Qualifiers
Patients with moderate to severe COPD and initiating BGF treatment according to the local prescribing guidance and as per their treating physician's recommendation
Enrolled in on-going single-arm studies
Provided consent for secondary use of data
Disqualifiers
Did not provide consent for secondary use of data
Trial design
Treatments tested in this trial
- Budesonide/glycopyrrolate/formoterol fumarate
Treatment groups
2,000 Participants
are divided into 1 treatment groupSponsors and collaborators
AstraZeneca
Lead sponsor
IQVIA Pty Ltd
Collaborator
Source ClinicalTrials.gov